GO:0004760 L-serine:pyruvate transaminase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004760 describes the molecular function that catalyzes the reversible conversion of L-serine and pyruvate into 3-hydroxypyruvate and L-alanine.
• The enzyme is widely distributed across animal species, with activity detected in liver cytosol and mitochondria.
• Hepatic L-serine:pyruvate transaminase activity is strongly associated with gluconeogenesis and is induced under gluconeogenic conditions.
• Developmental and hormonal signals, including cyclic AMP and cortisone, regulate the enzyme in neonatal and regenerating rat liver.
• Subcellular fractionation studies show distinct cytosolic and mitochondrial pools of the enzyme in rat liver.
• The reaction provides a metabolic link between serine catabolism, alanine production, and hydroxypyruvate metabolism.
Description
L-serine:pyruvate transaminase activity (GO:0004760) is a molecular function that catalyzes the reversible transfer of an amino group from L-serine to pyruvate, yielding 3-hydroxypyruvate and L-alanine. This reaction sits at the intersection of amino acid metabolism and gluconeogenesis, because it both consumes serine and generates alanine, a key gluconeogenic precursor. The enzyme has been studied for decades in mammalian liver, where its activity changes with nutritional and hormonal status. Researchers value GO:0004760 because it provides a defined functional annotation for genes and proteins that mediate serine-pyruvate interconversion, enabling comparative studies across species and experimental models. Understanding this activity helps clarify how cells balance nitrogen and carbon fluxes during fasting, development, and regeneration.
L-serine:pyruvate transaminase activity At A Glance
| GO ID | GO:0004760 |
|---|---|
| GO term | L-serine:pyruvate transaminase activity |
| Ontology | molecular_function |
| Synonym | SPT; serine--pyruvate aminotransferase activity; L-serine:pyruvate aminotransferase activity |
| Major function | Reversible transamination between L-serine and pyruvate to form 3-hydroxypyruvate and L-alanine |
| Reaction | L-serine + pyruvate = 3-hydroxypyruvate + L-alanine |
| Subcellular location | Cytosol and mitochondria in rat liver |
| Physiological context | Associated with gluconeogenesis and serine catabolism |
| Regulation | Developmental, hormonal (cyclic AMP, cortisone) and nutritional signals |
What Is GO:0004760?
GO:0004760 is defined as the catalysis of the reaction: L-serine + pyruvate = 3-hydroxypyruvate + L-alanine. In other words, it is a transaminase (aminotransferase) activity that moves an amino group from serine to pyruvate, producing hydroxypyruvate and alanine. The reaction is reversible and does not require a net change in oxidation state; it relies on a pyridoxal phosphate-type cofactor mechanism typical of transaminases. The term is a molecular_function in the Gene Ontology and is synonymous with serine--pyruvate aminotransferase activity, SPT, and related names.
Why Is L-serine:pyruvate transaminase activity Important in Cell Biology?
GO:0004760 is important because it defines a metabolic node that connects serine catabolism to alanine production and hydroxypyruvate metabolism, directly influencing gluconeogenic flux in liver and other tissues. Its activity is not static: it changes during neonatal development, in regenerating liver, and under gluconeogenic conditions, making it a sensitive marker of metabolic state. Because the enzyme exists in both cytosolic and mitochondrial compartments, it also informs studies of compartmentalized amino acid metabolism. For researchers, annotating a gene with GO:0004760 provides a precise functional handle for comparative biochemistry, disease modeling, and metabolic engineering.
• Links serine catabolism to alanine and hydroxypyruvate production.
• Supports gluconeogenic flux under fasting or low-carbohydrate conditions.
• Shows developmental regulation in neonatal rat liver.
• Responds to cyclic AMP and cortisone in regenerating rat liver.
• Exhibits species-specific activity differences across animals.
• Has distinct cytosolic and mitochondrial pools in rat liver.
• Provides a functional annotation for comparative genomics and enzymology.
• Serves as a potential target for studying metabolic reprogramming in disease.
Molecular Mechanism of L-serine:pyruvate transaminase activity
Substrate recognition and binding
In simple terms: The enzyme grabs L-serine and pyruvate and holds them in place.
The enzyme binds L-serine and pyruvate as its two substrates. The reaction is reversible, so it can also use 3-hydroxypyruvate and L-alanine as substrates in the reverse direction. Substrate specificity studies in rat liver cytosol and mitochondria indicate that the enzyme recognizes the amino acid and keto acid pair with defined stereochemistry.
Transamination chemistry
In simple terms: The enzyme moves an amino group from serine to pyruvate.
The catalytic step transfers the alpha-amino group of L-serine to pyruvate, forming 3-hydroxypyruvate and L-alanine. This is a classic transaminase reaction that proceeds through a pyridoxal phosphate-bound intermediate, although the exact cofactor identity is inferred from the enzyme class rather than directly cited in the provided literature. The reaction does not involve a net oxidation-reduction of the carbon skeleton.
Subcellular compartmentation
In simple terms: The enzyme works in two different parts of the cell.
In rat liver, L-serine:pyruvate aminotransferase activity is found in both the cytosol and mitochondria. Subcellular distribution studies show that these pools can be separated biochemically, suggesting distinct metabolic roles for each compartment. This compartmentation may allow the enzyme to participate in different pathways depending on the cell's metabolic needs.
Physiological regulation
In simple terms: The enzyme's activity goes up or down depending on the body's needs.
Hepatic activity increases under gluconeogenic conditions, such as fasting or diabetes-like states, linking the enzyme to glucose production. In neonatal rats, activity changes during development, and in regenerating liver it responds to cyclic AMP and cortisone. These regulatory patterns indicate that the enzyme is not constitutively active but is tuned to the organism's metabolic and hormonal status.
Species and tissue distribution
In simple terms: Different animals have different amounts of this enzyme.
Comparative studies show that L-serine:pyruvate aminotransferase activity varies across animal species, with the highest activity typically found in liver. This species variation suggests evolutionary differences in serine and pyruvate metabolism. Such data are useful for choosing appropriate model organisms for metabolic research.
Key Genes Involved in GO:0004760 L-serine:pyruvate transaminase activity
The following genes and proteins are directly implicated in L-serine:pyruvate transaminase activity or its regulation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SPT (serine--pyruvate aminotransferase) | Catalyzes the transamination reaction | Core enzyme for GO:0004760; studied in liver metabolism |
| L-serine dehydratase | Competes for L-serine as substrate | Co-regulated with SPT in neonatal liver |
| Pyruvate carboxylase | Gluconeogenic enzyme | Provides pyruvate for the reaction |
| PEPCK | Gluconeogenic enzyme | Marks gluconeogenic conditions where SPT is induced |
| Cyclic AMP-dependent protein kinase | Signaling mediator | Mediates hormonal induction of SPT |
| Cortisone/glucocorticoid receptor | Hormonal regulator | Induces SPT in regenerating liver |
| Alanine aminotransferase | Related transaminase | Shares alanine/pyruvate metabolism |
| Glyoxylate aminotransferase | Related transaminase | Associated with gluconeogenesis |
| Mitochondrial SPT pool | Compartmentalized activity | Distinct from cytosolic pool |
| Cytosolic SPT pool | Compartmentalized activity | Main hepatic activity |
| Hepatocyte nuclear factor 4 alpha | Transcription factor | Potential regulator of metabolic genes (inferred from general liver biology) |
| PGC-1alpha | Transcriptional coactivator | Linked to gluconeogenic gene programs (inferred) |
| Fasting-induced transcription factors | Metabolic regulators | Induce gluconeogenic enzymes including SPT |
| Insulin signaling components | Hormonal regulation | Oppose gluconeogenic induction (inferred) |
| Glucagon receptor | Hormonal regulation | Stimulates cyclic AMP and SPT activity |
| Pyridoxal phosphate-dependent enzymes | Cofactor usage | Transaminase mechanism (inferred from enzyme class) |
How Is L-serine:pyruvate transaminase activity Regulated?
L-serine:pyruvate transaminase activity is regulated at multiple levels. In neonatal rat liver, activity changes during development, and it is induced under gluconeogenic conditions such as fasting or diabetes. Hormonal signals including cyclic AMP and cortisone increase the enzyme's activity in regenerating rat liver. The presence of distinct cytosolic and mitochondrial pools suggests that subcellular localization also contributes to regulation. These layers of control allow the enzyme to adapt to the organism's metabolic state.
L-serine:pyruvate transaminase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SPT | Gluconeogenic disorders | Liver-specific knockout mouse |
| SPT | Liver regeneration | Partial hepatectomy rat model |
| SPT | Neonatal metabolic adaptation | Developmental time-course in rats |
| SPT | Species-specific drug response | Comparative enzymology across species |
| SPT | Serine metabolism disorders | Patient-derived hepatocytes |
Metabolic disorders and gluconeogenesis
Because L-serine:pyruvate transaminase activity is induced under gluconeogenic conditions, dysregulation of this enzyme could contribute to metabolic disorders characterized by abnormal glucose production. Conditions such as diabetes or prolonged fasting may alter the enzyme's activity, affecting serine and alanine fluxes. Studying this activity in animal models helps clarify its role in whole-body glucose homeostasis.
Liver regeneration and injury
In regenerating rat liver, L-serine:pyruvate transaminase activity responds to cyclic AMP and cortisone, suggesting a role in the metabolic adaptation that accompanies liver regrowth. This makes the enzyme a potential marker or mediator of liver regeneration after injury or partial hepatectomy. Its developmental regulation in neonatal liver further supports a role in tissue growth and remodeling.
Species-specific metabolism and disease models
Comparative studies show that L-serine:pyruvate transaminase activity varies widely among animal species, which has implications for choosing disease models. A drug or genetic manipulation that targets this activity may have different effects in mice, rats, and humans. Understanding these differences is essential for translating findings from model organisms to human disease.
From L-serine:pyruvate transaminase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SPT loss alter gluconeogenesis? | Liver-specific SPT knockout mouse |
| Does a point mutation affect catalytic efficiency? | Knock-in of mutant SPT in hepatocytes |
| Where is SPT localized in the cell? | Tagged knock-in with fluorescent tag |
| Does SPT overexpression change serine levels? | Transgenic overexpression in liver |
| How does SPT respond to fasting? | Wild-type mouse fasting/refeeding study |
| What is the role of SPT in liver regeneration? | Partial hepatectomy with SPT knockout |
How to Study the L-serine:pyruvate transaminase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic activity assay | Conversion of L-serine and pyruvate to products | Validating SPT function in tissues |
| Subcellular fractionation | Cytosolic vs mitochondrial activity | Determining compartmentation |
| qPCR | SPT mRNA levels | Gene expression under fasting |
| RNA-seq | Transcriptome-wide changes | Identifying co-regulated metabolic genes |
| Western blot | SPT protein abundance | Confirming knockout or overexpression |
| Immunohistochemistry | Tissue localization of SPT | Liver zonation studies |
| Metabolomics | Serine, pyruvate, alanine, hydroxypyruvate levels | Flux analysis in knockout models |
| CRISPR screening | Genes affecting serine metabolism | Identifying synthetic lethal interactions |
Enzymatic activity assays
Direct measurement of L-serine:pyruvate transaminase activity in tissue homogenates or subcellular fractions is the classic method used in the foundational literature. These assays typically monitor the formation of 3-hydroxypyruvate or L-alanine using spectrophotometric or radiometric detection. They remain the gold standard for validating enzyme function in knockout or overexpression models.
Subcellular fractionation
Differential centrifugation separates cytosolic and mitochondrial fractions, allowing researchers to measure L-serine:pyruvate transaminase activity in each compartment. This method revealed that the enzyme exists in both pools in rat liver. It is essential for understanding compartment-specific metabolic roles.
Gene expression analysis
Quantitative PCR and RNA-seq can measure SPT mRNA levels under different conditions, such as fasting or hormonal treatment. These methods complement activity assays by showing whether regulation occurs at the transcriptional level. They are widely used in developmental and regeneration studies.
Comparative biochemistry
Measuring enzyme activity across different animal species provides insights into evolutionary conservation and metabolic diversity. Such studies require standardized assay conditions and tissue collection. They help identify suitable model organisms for translational research.
How CRISPR Can Be Used to Study GO:0004760 L-serine:pyruvate transaminase activity
Knockout
CRISPR knockout of the SPT gene can eliminate L-serine:pyruvate transaminase activity in cell models, allowing researchers to test its role in serine catabolism and gluconeogenesis. Liver-derived cell lines with SPT knockout can be used to measure changes in alanine and hydroxypyruvate production. Such models are essential for distinguishing the enzyme's contribution from other transaminases.
Point Mutation
Introducing point mutations in the SPT catalytic site can dissect the mechanism of transamination and identify residues critical for substrate binding. These models help validate enzyme kinetics and cofactor dependence. They are particularly useful when a disease-associated variant is suspected but not yet characterized.
Knock-in
Knock-in of a tagged SPT allele enables visualization of the enzyme's subcellular localization in live cells. This approach can confirm whether the protein localizes to cytosol, mitochondria, or both. It also allows affinity purification for interaction studies.
Overexpression
Overexpression of SPT in cell lines or transgenic animals can increase flux through the serine-pyruvate pathway, leading to altered alanine and hydroxypyruvate levels. Such models are useful for testing whether the enzyme is rate-limiting under specific metabolic conditions. They can also reveal feedback regulation.
How EDITGENE Supports L-serine:pyruvate transaminase activity Research
Researchers studying L-serine:pyruvate transaminase activity-related genes often need to determine whether a candidate gene is causally involved in serine and pyruvate metabolism. EDITGENE provides CRISPR-based cell models and screening services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for L-serine:pyruvate transaminase activity research.
Frequently Asked Questions About L-serine:pyruvate transaminase activity
What is L-serine:pyruvate transaminase activity?
It is the enzyme activity that catalyzes the reversible conversion of L-serine and pyruvate to 3-hydroxypyruvate and L-alanine, annotated as GO:0004760.
What genes are involved in L-serine:pyruvate transaminase activity?
The core gene encodes serine--pyruvate aminotransferase (SPT), but related metabolic genes include L-serine dehydratase and alanine aminotransferase.
Where is L-serine:pyruvate transaminase found in the cell?
In rat liver, the activity is found in both the cytosol and mitochondria.
How is L-serine:pyruvate transaminase regulated?
It is regulated by developmental, nutritional, and hormonal signals, including cyclic AMP and cortisone.
What is the reaction catalyzed by GO:0004760?
The reaction is L-serine + pyruvate = 3-hydroxypyruvate + L-alanine.
Is L-serine:pyruvate transaminase involved in gluconeogenesis?
Yes, its activity increases under gluconeogenic conditions, linking it to glucose production.
Which species have L-serine:pyruvate transaminase activity?
Activity has been detected in multiple animal species, with highest levels typically in liver.
How can I study L-serine:pyruvate transaminase activity in the lab?
Common methods include enzymatic activity assays, subcellular fractionation, and gene expression analysis.
What diseases are associated with L-serine:pyruvate transaminase activity?
It has been linked to metabolic disorders and liver regeneration through its role in gluconeogenesis and hormonal response.
Can CRISPR be used to study L-serine:pyruvate transaminase activity?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect its function.
Conclusion
GO:0004760 L-serine:pyruvate transaminase activity defines a central metabolic reaction that connects serine catabolism to alanine and hydroxypyruvate production. Decades of research have established its regulation by developmental, nutritional, and hormonal signals, as well as its subcellular compartmentation in liver. Understanding this activity provides insights into gluconeogenesis, liver regeneration, and species-specific metabolism. With modern CRISPR tools, researchers can now precisely manipulate the responsible genes to uncover causal roles in health and disease.
References
- 1. Snell K et al.. 1974. Regulation of hepatic L-serine dehydratase and L-serine-pyruvate aminotransferase in the developing neonatal rat.. Biochem J 144(3):519-31 PMID: 4377655
- 2. Rowsell EV et al.. 1973. Increased liver L-serine-pyruvate aminotransferase activity under gluconeogenic conditions.. Biochem J 134(1):349-51 PMID: 4723229
- 3. Rowsell EV et al.. 1979. L-serine dehydratase and L-serine-pyruvate aminotransferase activities in different animal species.. Comp Biochem Physiol B 63(4):543-55 PMID: 318433
- 4. Rowsell EV et al.. 1972. Liver L-serine-pyruvate aminotransferase activity in different animal species.. Biochem J 127(2):27P PMID: 5076654
- 5. Hoshino J et al.. 1977. Regulation and characterization of L-serine: pyruvate aminotransferase in rat liver cytosol and mitochondria.. Z Naturforsch C Biosci 32(3-4):249-53 PMID: 17958
- 6. Hoshino J et al.. 1974. Proceedings: Regulatory changes in the activity of L-serine: pyruvate aminotransferase and its response to cyclic AMP and cortisone in regenerating rat liver.. Hoppe Seylers Z Physiol Chem 355(10):1210 PMID: 4376774
- 7. Rowsell EV et al.. 1969. Liver-L-alanine-glyoxylate and L-serine-pyruvate aminotransferase activities: an apparent association with gluconeogenesis.. Biochem J 115(5):1071-3 PMID: 5360676
- 8. Rowsell KV et al.. 1982. The subcellular distribution of rat liver serine-pyruvate aminotransferase.. Biochem J 202(2):483-90 PMID: 7092827
